Lanean...
Biomarkers in the Assessment of Therapies for Familial Amyloidotic Polyneuropathy
The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test drug efficiency in clinical trials. We previously demonstrated that in familial amyloidotic polyneuropathy (FAP) related to the abnormal extracellular tissue...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
ScholarOne
2007
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2017105/ https://ncbi.nlm.nih.gov/pubmed/17932549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00068.Macedo |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|